---
title: "12 Health Care Stocks Moving In Thursday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288754799.md"
description: "On Thursday, several healthcare stocks experienced significant intraday volatility. Veru surged 158.2% to $5.81, while Health Catalyst, Indaptus Therapeutics, SciSparc, BGM Group, and Absci also posted substantial gains. Conversely, ADC Therapeutics plummeted 54.4% to $1.41, with Inotiv, Aditxt, Basel Medical Group, Decoy Therapeutics, and AIM ImmunoTech recording notable declines."
datetime: "2026-06-04T17:06:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288754799.md)
  - [en](https://longbridge.com/en/news/288754799.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288754799.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Thursday's Intraday Session

### Gainers

-   **Veru** (NASDAQ:VERU) stock moved upwards by 158.2% to $5.81 during Thursday's regular session. The company's market cap stands at $36.1 million.
-   **Health Catalyst** (NASDAQ:HCAT) shares rose 35.34% to $1.8. The market value of their outstanding shares is at $98.2 million.
-   **Indaptus Therapeutics** (NASDAQ:INDP) stock moved upwards by 29.18% to $2.85. The market value of their outstanding shares is at $250.2 million.
-   **SciSparc** (NASDAQ:SPRC) shares rose 23.99% to $11.73. The company's market cap stands at $5.3 million.
-   **BGM Group** (NASDAQ:BGM) stock increased by 20.77% to $0.35. The company's market cap stands at $58.2 million.
-   **Absci** (NASDAQ:ABSI) shares rose 18.6% to $7.04. The market value of their outstanding shares is at $926.0 million.

### Losers

-   **ADC Therapeutics** (NYSE:ADCT) shares decreased by 54.4% to $1.41 during Thursday's regular session. The market value of their outstanding shares is at $391.7 million.
-   **Inotiv** (NASDAQ:NOTV) shares declined by 30.21% to $0.08. The market value of their outstanding shares is at $4.1 million.
-   **Aditxt** (NASDAQ:ADTX) stock fell 20.76% to $0.08.
-   **Basel Medical Group** (NASDAQ:BMGL) shares decreased by 17.04% to $0.54. The market value of their outstanding shares is at $12.3 million.
-   **Decoy Therapeutics** (NASDAQ:DCOY) stock decreased by 14.81% to $6.79. The market value of their outstanding shares is at $4.2 million.
-   **AIM ImmunoTech** (AMEX:AIM) stock decreased by 13.27% to $0.63. The company's market cap stands at $10.6 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [AIM.US](https://longbridge.com/en/quote/AIM.US.md)
- [ADTX.US](https://longbridge.com/en/quote/ADTX.US.md)
- [ADCT.US](https://longbridge.com/en/quote/ADCT.US.md)
- [HCAT.US](https://longbridge.com/en/quote/HCAT.US.md)
- [NOTV.US](https://longbridge.com/en/quote/NOTV.US.md)
- [BMGL.US](https://longbridge.com/en/quote/BMGL.US.md)
- [BGM.US](https://longbridge.com/en/quote/BGM.US.md)
- [DCOY.US](https://longbridge.com/en/quote/DCOY.US.md)
- [INDP.US](https://longbridge.com/en/quote/INDP.US.md)
- [ABSI.US](https://longbridge.com/en/quote/ABSI.US.md)
- [VERU.US](https://longbridge.com/en/quote/VERU.US.md)
- [SPRC.US](https://longbridge.com/en/quote/SPRC.US.md)
- [NOTVQ.US](https://longbridge.com/en/quote/NOTVQ.US.md)
- [AIMID.US](https://longbridge.com/en/quote/AIMID.US.md)
- [AIMI.US](https://longbridge.com/en/quote/AIMI.US.md)

## Related News & Research

- [Absci (ABSI) Could Be 32% Undervalued Following ABS 201 Data And Earnings](https://longbridge.com/en/news/295686913.md)
- [AbSci: Buy Rating Reaffirmed as ABS-201 Hair-Loss Program Advances; $11 Price Target Maintained](https://longbridge.com/en/news/295652271.md)
- [Scisparc posts audited 2025 net loss of USD 12.56 million](https://longbridge.com/en/news/296357022.md)
- [Veru Chief Scientific Officer Gary Barnette acquires $4,841.82 in common shares](https://longbridge.com/en/news/296143031.md)
- [SciSparc subsidiary NeuroThera Labs raises C$5.4 million in private placements](https://longbridge.com/en/news/296225798.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**